a-D-吡喃阿洛糖 | 7282-79-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: a-D-吡喃阿洛糖
• 英文名称: α-D-allose
• 英文别名: α-D-allopyranose；β-D-Allose；alpha-D-allopyranose；(2S,3R,4R,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol
• CAS: 7282-79-3
• 化学式: C₆H₁₂O₆
• 分子量: 180.158
• InChiKey: WQZGKKKJIJFFOK-UKFBFLRUSA-N

物化性质

• 沸点：
  410.8±45.0 °C(Predicted)
• 密度：
  1.732±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -2.6
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  110
• 氢给体数：
  5
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  a-D-吡喃阿洛糖 在 sodium hydroxide 作用下， 生成 葡糖酸
  参考文献：
  名称：

  High surface area mesoporous CuO: a high-performance electrocatalyst for non-enzymatic glucose biosensing

  摘要：

  高比表面积介孔CuO已成功用于构建酶促葡萄糖传感器。

  DOI：

  10.1039/c4ra04700a
• 作为产物：
  描述：

  D-Allose-2,4,6-triphosphat 生成 a-D-吡喃阿洛糖
  参考文献：
  名称：

  MULLER, DANIEL;PITSCH, STEFAN;KITTAKA, ATSUSHI;WAGNER, ERNST;WINTNER, CAL+, HELV. CHIM. ACTA , 73,(1990) N, C. 1410-1468

  摘要：

  DOI：

文献信息

• [EN] TRANSACETALISATION PROCESS<br/>[FR] METHODE DE TRANSACETALISATION
  申请人：UNIV MONASH

  公开号：WO2005070911A1

  公开（公告）日：2005-08-04

  The invention relates to the resolution of racemic mixtures, and in particular to the separation of enantiomers of chiral alcohols utilising recyclable chiral auxiliaries. The present invention also relates to a process for preparing these recyclable chiral auxiliaries using an enantiomerically pure alcohol.

  这项发明涉及手性混合物的分离，特别是利用可回收手性辅助剂分离手性醇的对映体。本发明还涉及利用对映纯醇制备这些可回收手性辅助剂的方法。
• [EN] DERIVATIVES OF MONOSACCHARIDES FOR DRUG DISCOVERY<br/>[FR] DERIVES DE MONOSACCHARIDES UTILISES POUR LA DECOUVERTE DE MEDICAMENTS
  申请人：ALCHEMIA PTY LTD

  公开号：WO2004014929A1

  公开（公告）日：2004-02-19

  New compounds and methods for the preparation of combinatorial libraries of potentially biologically active compounds are based on monosaccharides of formula (I) being a derivative of a furanose or pyranose form of a monosaccharide.

  新型化合物及制备组合化合物库的方法，该化合物库包含可能具有生物活性的化合物，其基础是通式(I)的单糖衍生物，该衍生物为呋喃糖或吡喃糖形式的单糖。
• POLYMER STABILIZER
  申请人：KIMURA Yoshikazu

  公开号：US20100179253A1

  公开（公告）日：2010-07-15

  A polymer stabilizer comprising the following alkoxy compound: the alkoxy compound: a compound obtained by alkoxylating at least one hydroxyl group contained in a compound of the following formula (1) containing one formyl group or carbonyl group and (n− 1 ) hydroxyl groups in the molecule with an alkyl group having 1 to 12 carbon atoms: C n H 2n O n (1) (wherein, n represents an integer of 3 or more).

  一种聚合物稳定剂，包含以下烷氧基化合物：所述烷氧基化合物是通过将含有以下通式（1）中的一个甲酰基或羰基以及分子中（n-1）个羟基的化合物中的至少一个羟基进行烷氧基化而得到的化合物，其中烷基团含有1至12个碳原子：CnH2nOn（1）（其中，n代表3或以上的整数）。
• Compositions for potentiating glutatthione
  申请人：Chiba Tomohiro

  公开号：US20060257351A1

  公开（公告）日：2006-11-16

  A composition for potentiating glutathione, which contains at least one member selected from the group consisting of 2-(3,4-dihydroxyphenyl)ethanol or a glycoside thereof, a plant containing 2-(3,4-dihydroxyphenyl)ethanol or a glycoside thereof, an extract of said plant, a hydrolysate of said plant, and a hydrolysate of the extract of said plant (excluding Olea europaea and an extract thereof), and which further contains at least one member selected from among an S-containing compound that is a supply source of cysteine, a protein that contains cysteine and/or cystine, a yeast that contains cysteine and/or cystine, and a vitamin.

  一种用于增强谷胱甘肽作用的组合物，包含至少从以下组合中选择的一种成员：2-(3,4-二羟基苯基)乙醇或其糖苷，含有2-(3,4-二羟基苯基)乙醇或其糖苷的植物，该植物的提取物，该植物的水解产物，以及该植物提取物的水解产物（不包括欧洲橄榄和其提取物），并且进一步包含至少从以下成员中选择的一种：供应半胱氨酸的含硫化合物，含有半胱氨酸和/或半胱氨酸的蛋白质，含有半胱氨酸和/或半胱氨酸的酵母，以及维生素。
• Mitochondrial Affinity of Guanidine-rich Molecular Transporters Built on Monosaccharide Scaffolds: Stereochemistry and Lipophilicity
  作者：Woo-Sirl Lee、Wan-Il Kim、Kyong-Tai Kim、Sung-Kee Chung

  DOI：10.5012/bkcs.2011.32.7.2286

  日期：2011.7.20

  We synthesized eight G8 molecular transporters (MTs) based on 4 different monosaccharide scaffolds, and studied their biological properties with a special focus on possible mitochondrial targeting and tissue selectivity. The mitochondrial affinity of these MTs was found to be clearly related to the scaffold stereochemistry and also tenuously with the lipophilicity. It may be suggested that in the practical delivery strategy of drugs for the brain and mitochondrial diseases the BBB permeability and mitochondrial affinity should be considered as key parameters, and that an enhanced mitochondrial affinity appears possible by further research on the structure-property relationship of guanidine-rich molecular transporters.

  我们合成了八种基于四种不同单糖支架的G8分子转运体（MTs），并研究了它们的生物特性，特别关注可能的线粒体靶向性和组织选择性。这些MT的线粒体亲和力明显与支架的立体化学相关，也与疏水性有一定联系。可以建议，在针对大脑和线粒体疾病的药物实际递送策略中，应将血脑屏障渗透性和线粒体亲和力视为关键参数，并且通过进一步研究富含胍的分子转运体的结构—性质关系，增强线粒体亲和力是可行的。